Intech Investment Management LLC Acquires 17,130 Shares of CVS Health Corporation $CVS

Intech Investment Management LLC boosted its stake in shares of CVS Health Corporation (NYSE:CVS) by 42.3% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 57,611 shares of the pharmacy operator’s stock after acquiring an additional 17,130 shares during the quarter. Intech Investment Management LLC’s holdings in CVS Health were worth $3,974,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of the stock. Avion Wealth lifted its position in CVS Health by 99.0% during the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 189 shares during the period. Harbor Asset Planning Inc. bought a new position in shares of CVS Health during the second quarter worth $30,000. Bell Investment Advisors Inc grew its stake in CVS Health by 119.8% in the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after acquiring an additional 248 shares during the period. Roxbury Financial LLC grew its position in shares of CVS Health by 78.3% in the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 202 shares during the period. Finally, ORG Partners LLC increased its position in shares of CVS Health by 418.9% during the second quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock worth $32,000 after acquiring an additional 377 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

Insider Activity at CVS Health

In related news, Director Anne A. Finucane sold 7,500 shares of the business’s stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total transaction of $532,650.00. Following the transaction, the director directly owned 22,156 shares of the company’s stock, valued at approximately $1,573,519.12. The trade was a 25.29% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.22% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently weighed in on CVS. Sanford C. Bernstein upped their price objective on CVS Health from $72.00 to $77.00 and gave the stock a “market perform” rating in a research report on Friday, September 5th. Evercore ISI upped their price target on CVS Health from $85.00 to $95.00 and gave the stock an “outperform” rating in a research report on Thursday, October 30th. Cowen reiterated a “buy” rating on shares of CVS Health in a report on Monday, August 4th. Robert W. Baird upgraded shares of CVS Health from a “neutral” rating to an “outperform” rating and increased their target price for the stock from $71.00 to $82.00 in a report on Thursday, August 14th. Finally, Jefferies Financial Group lifted their price target on shares of CVS Health from $92.00 to $98.00 in a research note on Thursday, October 30th. Two investment analysts have rated the stock with a Strong Buy rating, twenty-one have assigned a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $89.41.

CVS Health Price Performance

Shares of CVS opened at $78.24 on Tuesday. The company has a market cap of $99.32 billion, a price-to-earnings ratio of 205.89, a PEG ratio of 0.87 and a beta of 0.60. The company has a current ratio of 0.83, a quick ratio of 0.62 and a debt-to-equity ratio of 0.83. The company’s fifty day simple moving average is $77.86 and its 200 day simple moving average is $70.02. CVS Health Corporation has a 1-year low of $43.56 and a 1-year high of $85.15.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The company had revenue of $102.87 billion for the quarter, compared to analyst estimates of $98.85 billion. During the same period in the previous year, the business earned $1.09 EPS. CVS Health’s revenue for the quarter was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, research analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd were given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.4%. The ex-dividend date of this dividend was Thursday, October 23rd. CVS Health’s dividend payout ratio (DPR) is presently 700.00%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.